版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
EuropeanHeartJournal2010EuropeanHeartRhythmAssociation(EHRA);
EndorsedbytheEuropeanAssociationforCardio-ThoracicSurgery(EACTS)ESCGuidelines2010
onthemanagementof
AtrialFibrillationEuropeanHeartJournal(2010)31,2369-24292010ESC房颤指南英文2010ESC房颤指南英文Classesofrecommendations2010ESC房颤指南英文Levelsofevidence2010ESC房颤指南英文ClinicalEvents(outcomes)affectedbyAF2010ESC房颤指南英文Conditionspredisposingto,or
encouragingprogressionofAF2010ESC房颤指南英文TypesofAtrialFibrillation2010ESC房颤指南英文Clinicalevaluation2010ESC房颤指南英文StructuralabnormalitiesassociatedwithAF2010ESC房颤指南英文EHRAscoreofAF-
relatedsymptomsAF=atrialfibrillation;EHRA=EuropeanHeartRhythmAssociation2010ESC房颤指南英文NaturaltimecourseofAFAF=atrialfibrillation2010ESC房颤指南英文DiagnosisandinitialmanagementofAFaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;ECG=electrocardiogram;EHRA=EuropeanHeartRhythmAssociation.2010ESC房颤指南英文DiagnosisandinitialmanagementofAFaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;ECG=electrocardiogram.2010ESC房颤指南英文DiagnosisandinitialmanagementofAFaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;ECG=electrocardiogram.2010ESC房颤指南英文ThemanagementcascadeforpatientswithAFACEI=angiotensin-convertingenzymeinhibitor;AF=atrialfibrillation;ARB=angiotensinreceptorblocker;
PUFA=polyunsaturatedfattyacid;TE=thrombo-embolism.2010ESC房颤指南英文CHADS2scoreandstrokerate*Theadjustedstrokeratewasderivedfromthemultivariableanalysisassumingnoaspirinusage;thesestrokeratesare
basedondatafromacohortofhospitalisedAFpatients,publishedin2001,withlownumbersinthosewithaCHADS2score
of5and6toallowanaccuratejudgementoftheriskinthesepatients.Giventhatstrokeratesaredecliningoverall,actual
strokeratesincontemporarynon-hospitalisedcohortsmayalsovaryfromtheseestimates.AdaptedfromGageBFetal. AF=atrialfibrillation;CHADS2=cardiacfailure,hypertension,age,diabetes,stroke(doubled).2010ESC房颤指南英文Riskfactorsforstrokeand
thrombo-embolisminnon-valvularAFAF=atrialfibrillation;EF=ejectionfraction(asdocumentedbyechocardiography,radionuclideventriculography,cardiac
catheterization,cardiacmagneticresonanceimaging,etc.);LV=leftventricular;TIA=transientischaemicattack.2010ESC房颤指南英文Riskfactor-basedpoint-basedscoring
system-CHA2DS2-VASc
*Priormyocardialinfarction,peripheralarterydisease,aorticplaque.Actualratesofstrokeincontemporary
cohortsmayvaryfromtheseestimates.2010ESC房颤指南英文Adjustedstrokerateaccording
toCHA2DS2-VAScscore2010ESC房颤指南英文Useoforalanticoagulationfor
strokepreventioninAFAF=atrialfibrillation;OAC=oralanticoagulant;TIA=transientischaemicattack.2010ESC房颤指南英文ApproachtothromboprophylaxisinAFAF=atrialfibrillation;CHA2DS2-VASc=cardiacfailure,hypertension,age≥75(doubled),diabetes,stroke(doubled)-vasculardisease,age65–74andsexcategory(female);INR=internationalnormalizedratio;OAC=oralanticoagulation,suchasavitaminKantagonist(VKA)adjustedtoanintensityrangeofINR2.0–3.0(target2.5).2010ESC房颤指南英文TheHAS-BLEDbleedingriskscore*Hypertensionisdefinedassystolicbloodpressure>160mmHg.INR=internationalnormalizedratio.2010ESC房颤指南英文Cardioversion,TOEandanticoagulationAF=atrialfibrillation;DCC=directcurrentcardioversion;LA=leftatrium;LAA=leftatrialappendage;OAC=oralanticoagulant;
SR=sinusrhythm;TOE=transoesophagealechocardiography.2010ESC房颤指南英文PreventionofthromboembolisminAF2010ESC房颤指南英文PreventionofthromboembolisminAF2010ESC房颤指南英文aClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;CHADS2=cardiacfailure,hypertension,age,diabetes,stroke(doubled);
INR=internationalnormalizedratio;LMWH=lowmolecularweightheparin;OAC=oralanticoagulant;TIA=transientischaemicattack;VKA=vitaminKantagonist.PreventionofthromboembolisminAF2010ESC房颤指南英文Drugsanddosesforpharmacological
conversionof(recent-onset)AF
ACS=acutecoronarysyndrome;AF=atrialfibrillation;DCC=directcurrentcardioversion;i.v.=intravenous;
N/A=notapplicable;NYHA,NewYorkHeartAssociation;p.o.=peros;QRS=QRSduration;QT=QTinterval;
T-U=abnormalrepolarization(T-U)waves.2010ESC房颤指南英文DCCandpharmacologicalconversion
recent-onsetAFAF=atrialfibrillation;i.v.=intravenous.2010ESC房颤指南英文PharmacologicalcardioversionofAFaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;LoE=levelofevidence;i.v.=intravenous.2010ESC房颤指南英文DCcardioversionforAFaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;DCC=directcurrentcardioversion.2010ESC房颤指南英文GeneralManagementoftheAFPatient2010ESC房颤指南英文Choiceofrateandrhythmcontrolstrategies2010ESC房颤指南英文RateandrhythmcontrolofAFaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;EHRA=EuropeanHeartRhythmAssociation.2010ESC房颤指南英文Optimallevelofheartratecontrol2010ESC房颤指南英文RatecontrolofatrialfibrillationThechoiceofdrugsdependsonlifestyleandunderlyingdisease2010ESC房颤指南英文Drugsfor
ratecontrolER=extendedreleaseformulations;N/A=notapplicable.‡Onlyinpatientswithnon-permanentatrialfibrillation.2010ESC房颤指南英文AcuteratecontrolinAFaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;i.v.=intravenous.2010ESC房颤指南英文Long-termratecontrolinAF
aClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;bmp=beatsperminute;LV=leftventricular;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文Long-termratecontrolinAF
aClassofrecommendation.bLevelofevidence.
AF=atrialfibrillation;bmp=beatsperminute;LV=leftventricular;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文AVnodeablationinAFpatientsaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;AV=atrioventricular;CRT=cardiacresynchronizationtherapy;LV=leftventricular;
LVEF=leftventricularejectionfraction;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文AVnodeablationinAFpatientsaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;AV=atrioventricular;CRT=cardiacresynchronization
therapy;LV=leftventricular;LVEF=leftventricularejectionfraction;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文Choiceofpacemakersafter
AVnodeablationaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;AV=atrioventricular;CRT=cardiacresynchronizationtherapy;LV=leftventricular;
LVEF=leftventricularejectionfraction;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文Principlesofantiarrhythmicdrug
therapytomaintainsinusrhythmTreatmentismotivatedbyattemptstoreduceAF-related
symptoms.Efficacyofantiarrhythmicdrugstomaintainsinusrhythmismodest.Clinicallysuccessfulantiarrhythmicdrugtherapymayreducerather
thaneliminaterecurrenceofAF.Ifoneantiarrhythmicdrug‘fails’aclinicallyacceptableresponse
maybeachievedwithanotheragent.Drug-inducedproarrhythmiaorextra-cardiacside-effectsare
frequent.Safetyratherthanefficacyconsiderationsshouldprimarilyguide
thechoiceofantiarrhythmicagent.2010ESC房颤指南英文Suggesteddosesandmaincaveatsfor
commonlyusedantiarrhythmicdrugsAF=atrialfibrillation;AV=atrioventricular;bpm=beatsperminute;CYP=cytochromeP;ECG=electrocardiogram;
LV=leftventricular;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文Suggesteddosesandmaincaveatsfor
commonlyusedantiarrhythmicdrugs
(Contd)AF=atrialfibrillation;AV=atrioventricular;bpm=beatsperminute;CYP=cytochromeP;ECG=electrocardiogram;
LV=leftventricular;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文Suggesteddosesandmaincaveatsfor
commonlyusedantiarrhythmicdrugs
(Contd)AF=atrialfibrillation;AV=atrioventricular;bpm=beatsperminute;CYP=cytochromeP;ECG=electrocardiogram;
LV=leftventricular;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文Choiceofantiarrhythmicforthepatient
withnoorminimalstructuralheartdisease2010ESC房颤指南英文Choiceofantiarrhythmicdrug
accordingtounderlyingpathologyACEI=angiotensin-convertingenzymeinhibitor;ARB=angiotensinreceptorblocker;CAD=coronaryarterydisease;CHF=congestiveheartfailure;
HT=hypertension;LVH=leftventricularhypertrophy;NYHA=NewYorkHeartAssociation;unstable=cardiacdecompensationwithintheprior
4weeks.Antiarrhythmicagentsarelistedinalphabeticalorderwithineachtreatmentbox.?=evidencefor‘upstream’therapyforpreventionofatrial
remodellingstillremainscontroversial.2010ESC房颤指南英文Choiceofanantiarrhythmicdrug
forAFcontrolaClassofrecommendation.bLevelofevidence.
AF=atrialfibrillation;AV=atrioventricular;LoE=levelofevidence;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文Choiceofanantiarrhythmicdrug
forAFcontrolaClassofrecommendation.bLevelofevidence.
AF=atrialfibrillation;AV=atrioventricular;LoE=levelofevidence;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文Choiceofanantiarrhythmicdrug
forAFcontrolaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;AV=atrioventricular;LoE=levelofevidence;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文Choicebetweenablationandantiarrhythmicdrugtherapy
forpatientswithandwithoutstructuralheartdisease†MoreextensiveLAablationmaybeneeded;*usuallyPVIisappropriate.
AF=atrialfibrillation;CAD=coronaryarterydisease;CHF=congestiveheartfailure;HT=hypertension;LVH=leftventricularhypertrophy;
NYHA=NewYorkHeartAssociation;PVI=pulmonaryveinisolation.Antiarrhythmicagentsarelistedinalphabeticalorderwithineachtreatmentbox.2010ESC房颤指南英文LeftatrialcatheterablationaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;i.v.=intravenous;LMWH=lowmolecularweight
heparin;OAC=oralanticoagulant;UFH=unfractionatedheparin.2010ESC房颤指南英文LeftatrialcatheterablationaClassofrecommendation.
bLevelofevidence.
AF=atrialfibrillation;i.v.=intravenous;LMWH=lowmolecularweightheparin;OAC=oralanticoagulant;
UFH=unfractionatedheparin.2010ESC房颤指南英文SurgicalablationofAFaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation.2010ESC房颤指南英文PrimarypreventionofAF
with“upstream”therapyaClassofrecommendation.bLevelofevidence.ACEI=angiotensin-convertingenzymeinhibitor;AF=atrialfibrillation;ARB=angiotensinreceptorblocker.2010ESC房颤指南英文SecondarypreventionofAF
with“upstream”therapyaClassofrecommendation.bLevelofevidence.ACEI=angiotensin-convertingenzymeinhibitor;AF=atrialfibrillation;ARB=angiotensinreceptorblocker.2010ESC房颤指南英文RatecontrolduringAFwithheartfailureaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;AP=accessorypathway;LVEF=leftventricularejectionfraction.2010ESC房颤指南英文RatecontrolduringAFwithheartfailureaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;AV=atrioventricular;CRT=cardiacresynchronizationtherapy;
LVEF=leftventricularejectionfraction;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文RhythmcontrolofAFinheartfailureaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;DCC=directcurrentcardioversion;NYHA=NewYorkHeartAssociation.2010ESC房颤指南英文AtrialFibrillationinathletesaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation.2010ESC房颤指南英文AtrialFibrillationinvalvularheartdiseaseaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;INR=internationalnormalizedratio;LA=leftatrial;LV=leftventricular.2010ESC房颤指南英文AtrialFibrillationin
acutecoronarysyndromesaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation,ACS=acutecoronarysyndrome;DCC=directcurrentcardioversion.2010ESC房颤指南英文AtrialFibrillationin:aClassofrecommendation.bLevelofevidence.AF=atrialfibrillation,ECG=electrocardiogram.2010ESC房颤指南英文AtrialFibrillationinpregnancyaClassofrecommendation.bLevelofevidence.AF=atrialfibrillation;DCC=directcurrentcardioversion;LMWH=lowmolecularweightheparin;
UFH=unfractionatedheparin;VKA=vitaminKantagonist.20
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 北京交通大学《计算传播综合实践》2023-2024学年第一学期期末试卷
- 拆除回收合同范例
- 二零二四年度电动伸缩门生产工艺改进合同2篇
- 打瓜籽购销合同范例
- 二零二四年度房屋买卖合同(二手市场)
- 北京市协议采购合同范例
- 店招广告合同模板
- 建圈舍合同范例
- 2024建筑施工合同合同范本
- 二零二四年度文化场馆标识标牌制作合同
- 11.2 树立正确的人生目标 (同步课件)-2024-2025学年统编版道德与法治七年级上册
- 经济法学-计分作业二(第1-6章权重25%)-国开-参考资料
- 车联网在线升级( OTA )安全技术要求与测试方法 征求意见稿
- 华能新能源股份有限公司招聘笔试题库2024
- 消费者画像构建与细分
- 河南国有资本运营集团有限公司招聘笔试题库2024
- 【课件】鱼教学课件-2024-2025学年人教版生物七年级上册
- 庆祝第75个国庆节共筑中国梦大国华诞繁盛共享课件
- 2024年ADA糖尿病诊疗标准更新解读
- 2024-2030年中国少女内衣市场营销规模及未来销售趋势研究报告
- 2024-2030年中国PQQ行业市场发展分析及前景趋势与投资研究报告
评论
0/150
提交评论